M&T BANK CORP - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 251 filers reported holding QIAGEN NV in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of QIAGEN NV
ValueSharesWeighting
Q3 2023$729,159
-11.8%
18,019
-1.9%
0.00%0.0%
Q2 2023$827,156
+3.3%
18,361
+5.4%
0.00%0.0%
Q1 2023$800,463
-61.8%
17,428
-52.9%
0.00%
-25.0%
Q4 2022$2,095,822
+212.3%
37,017
+127.3%
0.00%
+33.3%
Q3 2022$671,000
+39.2%
16,288
+54.1%
0.00%
+50.0%
Q2 2022$482,000
+32.1%
10,568
+41.5%
0.00%0.0%
Q1 2022$365,000
+5.2%
7,469
+19.7%
0.00%
+100.0%
Q4 2021$347,000
+9.1%
6,240
+1.8%
0.00%0.0%
Q3 2021$318,000
-8.1%
6,127
-14.5%
0.00%
-50.0%
Q2 2021$346,000
-5.2%
7,166
-4.5%
0.00%0.0%
Q1 2021$365,000
-12.7%
7,502
-5.1%
0.00%0.0%
Q4 2020$418,000
+7.5%
7,907
+6.2%
0.00%0.0%
Q3 2020$389,000
+25.5%
7,448
+2.8%
0.00%0.0%
Q2 2020$310,000
+1.3%
7,244
-2.2%
0.00%0.0%
Q1 2020$306,000
+53.0%
7,408
+21.3%
0.00%
+100.0%
Q3 2019$200,000
-39.9%
6,105
-25.8%
0.00%
-50.0%
Q2 2019$333,000
+44.2%
8,230
+45.4%
0.00%
+100.0%
Q1 2019$231,000
+3.1%
5,662
-13.3%
0.00%0.0%
Q4 2018$224,000
-7.8%
6,533
+1.4%
0.00%0.0%
Q3 2018$243,000
+7.0%
6,440
+2.8%
0.00%0.0%
Q2 2018$227,000
+9.7%
6,262
-2.6%
0.00%0.0%
Q1 2018$207,000
+0.5%
6,430
-2.2%
0.00%0.0%
Q3 2017$206,000
-24.5%
6,572
-19.4%
0.00%
-50.0%
Q2 2017$273,000
+18.7%
8,155
+2.7%
0.00%
+100.0%
Q1 2017$230,0007,9400.00%
Other shareholders
QIAGEN NV shareholders Q4 2018
NameSharesValueWeighting ↓
SYCOMORE ASSET MANAGEMENT 2,368,913$86,182,00040.56%
Hardman Johnston Global Advisors LLC 4,407,084$151,824,0007.86%
Tikvah Management LLC 442,942$15,259,0005.41%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,594,057$88,155,0003.09%
Opus Point Partners Management, LLC 31,463$1,084,0002.39%
SECTOR GAMMA AS 407,406$14,035,0002.36%
SANDLER CAPITAL MANAGEMENT 804,049$27,699,0002.35%
Sivik Global Healthcare LLC 110,800$3,817,0002.06%
Acorn Advisory Capital L.P. 9,800$338,0001.21%
Eversept Partners, LP 55,300$1,905,0851.03%
View complete list of QIAGEN NV shareholders